Prestige Consumer Healthcare (PBH) EBT Margin Growth (3y) (2013 - 2025)
Prestige Consumer Healthcare (PBH) EBT Margin Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | 1,282.00 |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | -491.00 |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | 58.00 |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | -861.00 |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -1,020.00 |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | -995.00 |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 1,157.00 |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Prestige Consumer Healthcare | 2.44 Bn | 2.37 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -291.00 |
| Sep 30, 2025 | 220.00 |
| Jun 30, 2025 | -83.00 |
| Mar 31, 2025 | 210.00 |
| Dec 31, 2024 | 375.00 |
| Sep 30, 2024 | 367.00 |
| Jun 30, 2024 | -651.00 |
| Mar 31, 2024 | 732.00 |
| Dec 31, 2023 | 213.00 |
| Sep 30, 2023 | 274.00 |
| Jun 30, 2023 | -76.00 |
| Mar 31, 2023 | -12,489.00 |
| Dec 31, 2022 | 379.00 |
| Sep 30, 2022 | 453.00 |
| Jun 30, 2022 | 575.00 |
| Mar 31, 2022 | 9,712.00 |
| Dec 31, 2021 | 274.00 |
| Sep 30, 2021 | 341.00 |
| Jun 30, 2021 | 1,008.00 |
| Mar 31, 2021 | 3,752.00 |